Skip to main content

Table 1 Relationship between the relative expression of circADARB1 in plasma of NKTCL patients and the characteristics of clinical data

From: CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3

Clinical characteristics Group Cases P-value
Age  < 60 43 0.584
 ≥ 60 7
Sex Male 32 0.613
Female 18
B symptom With 26 0.497
Without 24
Stage I–II 38 0.525
III–IV 12
PINK-E Low 40 0.933
Intermediate and High 10
ECOG 0–2 44 0.610
3–5 6
Response to therapy CR, PR 37 0.041
SD, PD 13